Page last updated: 2024-10-22

amifostine anhydrous and Erythema Multiforme

amifostine anhydrous has been researched along with Erythema Multiforme in 2 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Erythema Multiforme: A skin and mucous membrane disease characterized by an eruption of macules, papules, nodules, vesicles, and/or bullae with characteristic bull's-eye lesions usually occurring on the dorsal aspect of the hands and forearms.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boccia, R1
Anné, PR1
Bourhis, J1
Brizel, D1
Daly, C1
Holloway, N1
Hymes, S1
Koukourakis, M1
Kozloff, M1
Turner, M1
Wasserman, T1
Hicsonmez, A1
Andrieu, MN1
Akyurek, S1
Karaca, M1
Cagar, A1
Ciner, F1
Kurtman, C1

Reviews

1 review available for amifostine anhydrous and Erythema Multiforme

ArticleYear
Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).
    International journal of radiation oncology, biology, physics, 2004, Sep-01, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amifostine; Blister; Child; Child, Preschool; Drug Erupt

2004

Other Studies

1 other study available for amifostine anhydrous and Erythema Multiforme

ArticleYear
In regard to Boccia et al.: assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP) (INT J RADIAT ONCOL BIOL PHYS 2004;60:302-309).
    International journal of radiation oncology, biology, physics, 2005, Mar-15, Volume: 61, Issue:4

    Topics: Amifostine; Blister; Erythema Multiforme; Humans; Male; Middle Aged; Radiation-Protective Agents; St

2005